Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Human Pathology (New York)
|
February 18, 2020
Persistent indolent pancolonic marginal zone lymphoma of MALT-type with plasmacytic differentiation - A rare post-transplant lymphoma?
Joanna M Chaffin, Natasha M Savage, Suash Sharma, et al.
JCI Insight
|
April 7, 2026
Chemotherapy-induced reactive myelopoiesis promotes expansion of immunosuppressive neutrophil-like monocytes in mice and humans
Huidong Shi, Zhi-Chun Ding, Ogacheko D Okoko, et al.
Journal for Immunotherapy of Cancer
|
July 26, 2022
Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy
Nada S Aboelella, Caitlin Brandle, Ogacheko Okoko, et al.
JAMA Oncology
|
March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial
Locke J Bryan, Carla Casulo, Pamela B Allen, et al.
JAMA Oncology
|
February 27, 2025
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial
Anand P Jillella, Sandra J Lee, Jessica K Altman, et al.
Leukemia & Lymphoma
|
December 6, 2021
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma
Ahmad S Halwani, Carlos Panizo, Iris Isufi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Human Pathology (New York)
|
February 18, 2020
Persistent indolent pancolonic marginal zone lymphoma of MALT-type with plasmacytic differentiation - A rare post-transplant lymphoma?
Joanna M Chaffin, Natasha M Savage, Suash Sharma, et al.
JCI Insight
|
April 7, 2026
Chemotherapy-induced reactive myelopoiesis promotes expansion of immunosuppressive neutrophil-like monocytes in mice and humans
Huidong Shi, Zhi-Chun Ding, Ogacheko D Okoko, et al.
Journal for Immunotherapy of Cancer
|
July 26, 2022
Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy
Nada S Aboelella, Caitlin Brandle, Ogacheko Okoko, et al.
JAMA Oncology
|
March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial
Locke J Bryan, Carla Casulo, Pamela B Allen, et al.
JAMA Oncology
|
February 27, 2025
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial
Anand P Jillella, Sandra J Lee, Jessica K Altman, et al.
Leukemia & Lymphoma
|
December 6, 2021
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma
Ahmad S Halwani, Carlos Panizo, Iris Isufi, et al.
Page
of 2